Search

Your search keyword '"Cardiac patients -- Conferences, meetings and seminars"' showing total 270 results
Start Over Descriptor "Cardiac patients -- Conferences, meetings and seminars"
270 results on '"Cardiac patients -- Conferences, meetings and seminars"'

1. Daxor Corp. Spotlights Benefits of BVA-100 Guided-Care at the AAHFN 20th Annual Meeting

Subjects
Daxor Corp. -- Conferences, meetings and seminars, Medical test kit industry -- Conferences, meetings and seminars, Medical equipment and supplies industry -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Arts and entertainment industries
Abstract

Daxor Corp., a company focusing on blood volume measurement technology, it is exhibiting at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting, which runs through 22, at [...]

Published
2024

2. Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings

Subjects
JPMorgan Chase & Co. -- Conferences, meetings and seminars, Strategic planning (Business) -- Conferences, meetings and seminars, Warfarin -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, Business, international
Abstract

Lays out Phase 3 Clinical and Regulatory Path for Tecarfarin and Three-Year Strategic Plan PONTE VEDRA, Fla. -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), announced today its engagement in three key [...]

Published
2024

3. Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference

Subjects
Rocket Pharmaceuticals Inc. -- Conferences, meetings and seminars, Conferences, meetings and seminars, Biotechnology industries -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Biotechnology industry -- Conferences, meetings and seminars
Abstract

All six evaluable Phase 1 patients with Danon disease are alive and transplant-free up to age 25 years RP-A501 demonstrated safety and meaningful efficacy; all evaluable patients show cardiac LAMP2 [...]

Published
2024

4. Thryv Therapeutics to Sponsor and Participate in the 2024 International SADS Foundation Family Conference in Chicago

Subjects
Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

MONTREAL: Thryv Therapeutics Inc. has issued the following news release: Thryv Therapeutics Inc., a clinical-stage biotechnology company, is proud to announce its sponsorship and active participation in the 2024 International [...]

Published
2024

5. Thryv Therapeutics to Sponsor and Participate in the 2024 International SADS Foundation Family Conference in Chicago

Subjects
Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

MONTREAL, Nov. 4, 2024 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company, is proud to announce its sponsorship and active participation in the 2024 International Sudden Arrhythmia Death Syndromes [...]

Published
2024

6. The Congestion Index Improves Heart Failure Event Prediction Relative to the Weight Rule

Author

Nye, Jessica

Subjects
United States. Food and Drug Administration -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Health
Abstract

The congestion index has a higher sensitivity than standard weight-based rules for detecting fluid accumulation preceding heart failure (HF) events, according to research presented at the Technology and Heart Failure [...]

Published
2024

7. New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

Subjects
Cardiac patients -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=roW7kR3lvL-QUcp94EY9Xz3B7yqDN4_crqt9SUNwmTHljbc8eVahSTQW3Zvl5IQKcSNBcx1kaHV4KY_wHQLGFg== Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce [...]

Published
2024

8. Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients

Subjects
United States. Food and Drug Administration -- Conferences, meetings and seminars, Anticoagulants (Medicine) -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

PONTE VEDRA: Cadrenal Therapeutics, Inc. has issued the following news release: Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) [...]

Published
2024

9. Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients

Subjects
United States. Food and Drug Administration -- Conferences, meetings and seminars, Anticoagulants (Medicine) -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

Tecarfarin, which recently received Orphan Drug Designation from the FDA for the prevention of thromboembolism and thrombosis in patients with an implanted mechanical circulatory support device, has the potential to [...]

Published
2024

10. Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting

Subjects
Johnson & Johnson -- Conferences, meetings and seminars -- Product development, Atrial fibrillation -- Conferences, meetings and seminars, Clinical trials -- Conferences, meetings and seminars, Heart -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Pharmaceutical industry -- Conferences, meetings and seminars -- Product development, General interest, News, opinion and commentary
Abstract

IRVINE: Biosense Webster has issued the following news release: Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced late-breaking results from [...]

Published
2024

11. Cardiol Therapeutics Presents Phase II ARCHER Trial Results at the 2024 Global Conference on Acute Heart Failure

Subjects
Clinical trials -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

Cardiol Therapeutics Inc. has announced a Phase II randomized, double-blind, placebo-controlled trial evaluating the impact of CardiolRxTM on myocardial recovery in patients with acute myocarditis (ARCHER). The trial, presented at [...]

Published
2024

12. Data on Clinical Trial Research Reported by Researchers at Icahn School of Medicine at Mount Sinai (Clinical Trial Design for Triglyceride-rich Lipoprotein-lowering Therapies Jacc Focus Seminar 3/3)

Subjects
United States. National Heart, Lung and Blood Institute -- Conferences, meetings and seminars, Medical research -- Conferences, meetings and seminars, Medicine, Experimental -- Conferences, meetings and seminars, Clinical trials -- Conferences, meetings and seminars, Triglycerides -- Conferences, meetings and seminars, Cardiovascular diseases -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Physical fitness -- Conferences, meetings and seminars, Health
Abstract

2023 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Clinical Trial Research. According to news reporting [...]

Published
2023

13. Research Conducted at Icahn School of Medicine at Mount Sinai Has Provided New Information about Biotechnology [Clinical Trial Design for Lipoprotein(A)-lowering Therapies Jacc Focus Seminar 2/3]

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Conferences, meetings and seminars, Cholesterol -- Conferences, meetings and seminars, Biotechnology -- Conferences, meetings and seminars, Clinical trials -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Monoclonal antibodies -- Conferences, meetings and seminars, Physical fitness -- Conferences, meetings and seminars, Pharmaceutical industry -- Conferences, meetings and seminars, Health
Abstract

2023 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Biotechnology. According to news reporting from New [...]

Published
2023

14. Roivios Secures FDA Breakthrough Device Designation for JuxtaFlow(r) RAD, Showcases Pioneering Data at Society of Cardiovascular Anesthesiologists Annual Meeting

Subjects
Medical equipment -- Conferences, meetings and seminars, Trade and professional associations -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Physiological apparatus -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

NASSAU, Bahamas: Roivios, ltd has issued the following news release: Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded [...]

Published
2024

15. STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

Subjects
CytoSorbents Corp. -- Forecasts and trends -- Conferences, meetings and seminars, Medical test kit industry -- Forecasts and trends -- Conferences, meetings and seminars, Securities law -- Conferences, meetings and seminars, Ticagrelor -- Conferences, meetings and seminars, Medical equipment and supplies industry -- Forecasts and trends -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

PRINCETON, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=GdPKtdhhNE1asYFTb5jMw6d4hK3f4cIMAUPqhs39fIZdYQZYdsGfPioZDdXwzrXkWm1UzYkaqIac3bURaN2YsVehFC34hG_GFZv6YhmMATU= (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification [...]

Published
2024

16. Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024

Subjects
Cardiovascular agents -- Conferences, meetings and seminars, Financial markets -- Conferences, meetings and seminars, Anticoagulants (Medicine) -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Company growth, General interest, News, opinion and commentary
Abstract

PONTE VEDRA, Fla: Cadrenal Therapeutics, Inc. has issued the following news release: Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood [...]

Published
2024

17. Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024

Subjects
Cardiovascular agents -- Conferences, meetings and seminars, Financial markets -- Conferences, meetings and seminars, Anticoagulants (Medicine) -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

PONTE VEDRA, Fla., April 11, 2024 /PRNewswire/ --Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart [...]

Published
2024

18. Multi-Center Study Presented By Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients

Subjects
Daxor Corp. -- Conferences, meetings and seminars, Medical centers -- Conferences, meetings and seminars, Medical test kit industry -- Conferences, meetings and seminars, Medical equipment and supplies industry -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

Oak Ridge: Daxor Corp announces new data from Duke University Medical Center validating the benefits of blood volume analysis in optimizing individualized therapy for heart failure patients with impaired renal [...]

Published
2024

19. Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients

Subjects
Daxor Corp. -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

Only Daxor's BVA Diagnostic Was Shown to Accurately Reflect Blood Volume Compared to Inferior Surrogates Oak Ridge, TN, March 08, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=0WipH7uTbCLZYzYUjA4F_bNb8LQ0HO4fGCLsGT75o4NsT56CMbLG8Hqa8lOE2HxPRCk_Y8fOm0zQ8HyxWsku85vKIDJDAS_ibdAfwPZQ_34= (Nasdaq: DXR), the global leader [...]

Published
2024

20. Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference

Subjects
Daxor Corp. -- Conferences, meetings and seminars, Medical test kit industry -- Conferences, meetings and seminars -- Exhibitions, Medical equipment and supplies industry -- Conferences, meetings and seminars -- Exhibitions, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

Oak Ridge, TN, Feb. 26, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=fXqzeKBMDjb-woZI6Ckn69zS6nVJ7KWx6OnEzUAbpAoY-kqcRfXatsizZmNrlJdFNdlp_TIiqNbGRAn2siNhXyV1avUAX-7JSvnew2VuZGg= (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the Technology and [...]

Published
2024

21. Biosense Webster announces late-breaking admIRE clinical trial results at HRS Annual Meeting in Boston

Subjects
Johnson & Johnson -- Conferences, meetings and seminars -- Product development, Atrial fibrillation -- Conferences, meetings and seminars, Clinical trials -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Pharmaceutical industry -- Conferences, meetings and seminars -- Product development, Business
Abstract

M2 EQUITYBITES-May 20, 2024-Biosense Webster announces late-breaking admIRE clinical trial results at HRS Annual Meeting in Boston (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Cardiac arrhythmia treatment specialist Biosense Webster Inc, part of [...]

Published
2024

22. Biosense Webster announces late-breaking admIRE clinical trial results at HRS Annual Meeting in Boston

Subjects
Johnson & Johnson -- Conferences, meetings and seminars -- Product development, Atrial fibrillation -- Conferences, meetings and seminars, Clinical trials -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Pharmaceutical industry -- Conferences, meetings and seminars -- Product development, Chemistry
Abstract

M2 PHARMA-May 20, 2024-Biosense Webster announces late-breaking admIRE clinical trial results at HRS Annual Meeting in Boston (C)2024 M2 COMMUNICATIONS Cardiac arrhythmia treatment specialist Biosense Webster Inc, part of Johnson [...]

Published
2024

23. BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference

Subjects
Conferences and conventions -- Conferences, meetings and seminars, Heart -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

SUNNYVALE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=1kOFJ30_CfF9liqJ415Eq6nyPZLAGudu5SvOOJWeaseltvxNb77bCVLvtHKIEW-wU7rHHKnA4u59H_1Y9bY3nQ== ('BioCardia' or the 'Company') (Nasdaq: BCDA), a biotechnology company focused on advancing late-stage cell therapy interventions for cardiovascular disorders, is targeting [...]

Published
2024

24. CytoSorbents hosted symposium on CytoSorb, announces presentation data

Subjects
Rivaroxaban -- Conferences, meetings and seminars, Transplantation of organs, tissues, etc. -- Conferences, meetings and seminars, Ticagrelor -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

CytoSorbents also hosted a lunch symposium entitled, 'Hemoadsorption with CytoSorb in high-risk cardiac surgery indications - new data' that drew approximately 150 attendees. Key presentations included: 'Clinical benefits in patients [...]

Published
2022

25. Akron Children's, GlobalCastMD to host conference on cardioneuroablation

Subjects
Heart beat -- Conferences, meetings and seminars, Arrhythmia -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

AKRON, Ohio, Sept. 11, 2023 /PRNewswire/ -- Akron Children's Hospital and GlobalCastMD will co-host the Second World Congress on Cardioneuroablation, a live, virtual conference, on Oct. 21 from 11 a.m. [...]

Published
2023

26. CareDx announces over 25 presentations, posters at ISHLT meeting

Subjects
Transplantation of organs, tissues, etc. -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Organ transplant recipients -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

CareDx announced a leading presence at the International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions, with over 25 oral presentations and posters covering the latest innovations [...]

Published
2022

27. Adona Medical's Next-Generation Heart Failure Management Platform Showcased at CSI Frankfurt 2023 Conference

Subjects
Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

Innovative platform designed for more personalized, tailored management of heart failure patients LOS GATOS, Calif., July 10, 2023 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3914567-1&h=3400462899&u=https%3A%2F%2Fwww.adonamed.com%2F&a=Adona+Medical, a Shifamed portfolio company that aims to deliver advanced [...]

Published
2023

28. MoyoAssist(r) Extra-VAD, a Promising Solution for the Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE

Subjects
Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Biomedical engineering -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

SUZHOU: The 4th Academic Annual Conference held by the Mechanical Circulatory Support (MCS) Branch of the Chinese Society of Biomedical Engineering (CSBE), one of the biggest academic gatherings that celebrate [...]

Published
2023

29. MoyoAssist Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE

Subjects
Cardiac patients -- Conferences, meetings and seminars, Biomedical engineering -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

SUZHOU, China, June. 16, 2023 /PRNewswire/ -- The 4th Academic Annual Conference held by the Mechanical Circulatory Support (MCS) Branch of the Chinese Society of Biomedical Engineering (CSBE), one of [...]

Published
2023

30. Avertix Medical to Participate in the Sidoti Summer Small Cap Conference

Subjects
Coronary heart disease -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Chief financial officers -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

EATONTOWN: Avertix Medical, Inc. ('Avertix'), a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, announced that [...]

Published
2023

31. Avertix to Participate in the Sidoti Summer Small Cap Conference

Subjects
Medical equipment -- Conferences, meetings and seminars, Coronary heart disease -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Chief financial officers -- Conferences, meetings and seminars, Physiological apparatus -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

EATONTOWN, N.J. and NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. ('Avertix' or the 'Company'), a company focused on improving long-term management and outcomes of high-risk coronary [...]

Published
2023

32. Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)

Author

Kneyber, Martin C. J., de Luca, Daniele, Calderini, Edoardo, Jarreau, Pierre-Henri, Javouhey, Etienne, Lopez-Herce, Jesus, and Hammer, Jürg

Subjects
Medical research -- Conferences, meetings and seminars, Medicine, Experimental -- Conferences, meetings and seminars, Societies -- Conferences, meetings and seminars, Medical colleges -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Neonatology -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Neonatal intensive care -- Conferences, meetings and seminars, Associations, institutions, etc. -- Conferences, meetings and seminars, Health care industry
Abstract

Purpose Much of the common practice in paediatric mechanical ventilation is based on personal experiences and what paediatric critical care practitioners have adopted from adult and neonatal experience. This presents a barrier to planning and interpretation of clinical trials on the use of specific and targeted interventions. We aim to establish a European consensus guideline on mechanical ventilation of critically children. Methods The European Society for Paediatric and Neonatal Intensive Care initiated a consensus conference of international European experts in paediatric mechanical ventilation to provide recommendations using the Research and Development/University of California, Los Angeles, appropriateness method. An electronic literature search in PubMed and EMBASE was performed using a combination of medical subject heading terms and text words related to mechanical ventilation and disease-specific terms. Results The Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) consisted of a panel of 15 experts who developed and voted on 152 recommendations related to the following topics: (1) general recommendations, (2) monitoring, (3) targets of oxygenation and ventilation, (4) supportive measures, (5) weaning and extubation readiness, (6) normal lungs, (7) obstructive diseases, (8) restrictive diseases, (9) mixed diseases, (10) chronically ventilated patients, (11) cardiac patients and (12) lung hypoplasia syndromes. There were 142 (93.4%) recommendations with 'strong agreement'. The final iteration of the recommendations had none with equipoise or disagreement. Conclusions These recommendations should help to harmonise the approach to paediatric mechanical ventilation and can be proposed as a standard-of-care applicable in daily clinical practice and clinical research., Author(s): Martin C. J. Kneyber [sup.1] [sup.2], Daniele de Luca [sup.3] [sup.4], Edoardo Calderini [sup.5], Pierre-Henri Jarreau [sup.6], Etienne Javouhey [sup.7] [sup.8], Jesus Lopez-Herce [sup.9] [sup.10], Jürg Hammer [sup.11], Duncan [...]

Published
2017
Full Text
View/download PDF

33. Daxor Corporation to Exhibit at the 43rd International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions

Subjects
Daxor Corp. -- Conferences, meetings and seminars, Transplantation of organs, tissues, etc. -- Conferences, meetings and seminars, Medical test kit industry -- Conferences, meetings and seminars -- Exhibitions, Medical equipment and supplies industry -- Conferences, meetings and seminars -- Exhibitions, Cardiac patients -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

Company to Showcase Three New Research Studies Utilizing Blood Volume Analysis Oak Ridge, TN, April 13, 2023 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=MC6RQ1MR6Ckxbiw9C2z2p0LqzinEmoSoJ1C2BR6w55aiUrX5DeCIv7BXYLRYkM4galcEhFVbvkj-jrZnhW9mNA== https://www.globenewswire.com/Tracker?data=kkixOlYedwBZVorAFQ5Judt59i2o_MAuSzsXcBE8fzkqXtz6K6yUurUYjJuZUn6_69OKvQjWbnToX3-Dxq5ez3v2Xma5ilTD0z8YymUWCVo= (Nasdaq: DXR), the global leader in blood volume [...]

Published
2023

34. CathWorks Announces Key Events for ACC 2023

Subjects
Coronary heart disease -- Conferences, meetings and seminars, Medical centers -- Conferences, meetings and seminars, Cardiology -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, General interest, News, opinion and commentary, American College of Cardiology -- Conferences, meetings and seminars
Abstract

KFAR-SABA: CathWorks has issued the following news release: CathWorks announced today key events for the company during the annual American College of Cardiology (ACC) 2023 conference taking place March 4 [...]

Published
2023

35. Attralus Highlights Clinical Data on AT-01 at the 2021 American College of Cardiology Annual Meeting

Subjects
Cardiology -- Conferences, meetings and seminars, Clinical trials -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Amyloidosis -- Conferences, meetings and seminars, Arts and entertainment industries
Abstract

Attralus recently reported presentation of clinical data at the 2021 American College of Cardiology (ACC) annual meeting by the company's co-founder and interim Chief Scientific Officer, Jonathan Wall, PhD, who [...]

Published
2021

36. Research Revolution Conference, Powered by Florence Healthcare, Tackles Slowdown in Drug Development Due to Trial Site Stress

Subjects
High technology industry -- Conferences, meetings and seminars, Health care reform -- Conferences, meetings and seminars, Medical research -- Conferences, meetings and seminars, Medicine, Experimental -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

ATLANTA: FLORENCE HEALTHCARE has issued the following news release: Research Revolution, a clinical trials conference organized by Florence Healthcare, welcomed more than 300 people to Atlanta, Georgia, November 1-3. During [...]

Published
2022

37. Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences

Subjects
Cardiovascular Systems Inc. -- Conferences, meetings and seminars, Coronary heart disease -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

ST. PAUL: CARDIOVASCULAR SYSTEMS, INC. has issued the following news release: Cardiovascular Systems, Inc. (CSI(r)) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients [...]

Published
2022

38. Research Revolution Conference, Powered by Florence Healthcare, Tackles Slowdown in Drug Development Due to Trial Site Stress

Subjects
High technology industry -- Conferences, meetings and seminars, Health care reform -- Conferences, meetings and seminars, Medical research -- Conferences, meetings and seminars, Medicine, Experimental -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, Business, international
Abstract

ATLANTA -- Research Revolution, a clinical trials conference organized by Florence Healthcare, welcomed more than 300 people to Atlanta, Georgia, November 1-3. During those three days, a clear trend emerged: [...]

Published
2022

39. Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences

Subjects
Cardiovascular Systems Inc. -- Conferences, meetings and seminars, Coronary heart disease -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, Business, international
Abstract

ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI([R])) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today [...]

Published
2022

40. HFSA TO RELEASE FOUR HEART FAILURE SEMINARS IN 2023

Subjects
Homeopathy -- Materia medica and therapeutics, Therapeutics -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, News, opinion and commentary
Abstract

ROCKVILLE, MD -- The following information was released by the Heart Failure Society of America (HFSA): In 2022, HFSA released two new HFSA Heart Failure Seminars, which are 1 1/2 [...]

Published
2022

41. Kayla Valigura Wins PCCA's 2022 International Seminar Pharmacy Student Scholarship Contest

Subjects
Seminars -- Conferences, meetings and seminars, Contests -- Conferences, meetings and seminars, Pharmacy -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

Houston: PCCA has issued the following press release: PCCA selected pharmacy student Kayla Valigura from the University of Houston College of Pharmacy as the winner of its 2022 International Seminar [...]

Published
2022

42. Kayla Valigura Wins PCCA's 2022 International Seminar Pharmacy Student Scholarship Contest

Subjects
Seminars -- Conferences, meetings and seminars, Contests -- Conferences, meetings and seminars, Pharmacy -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

Houston, Oct. 19, 2022 (GLOBE NEWSWIRE) -- PCCA selected pharmacy student Kayla Valigura from the University of Houston College of Pharmacy as the winner of its 2022 International Seminar Pharmacy [...]

Published
2022

43. New Data Evaluating ImpediMed's SOZO in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022

Subjects
Trade and professional associations -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Business, News, opinion and commentary
Abstract

BRISBANE, Australia and CARLSBAD, Calif., July 15, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) is pleased to announce that two abstracts evaluating use of ImpediMed's SOZO Digital Health Platform in [...]

Published
2022

44. Daxor Corporation to Showcase the Benefits of BVA-100(R) Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 18th Annual Meeting

Subjects
Daxor Corp. -- Conferences, meetings and seminars, Trade and professional associations -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Nurses -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Banking, finance and accounting industries, Business
Abstract

Oak Ridge, TN, Jun 13, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:DXR), EQNX::TICKER_END DaxorCorporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit [...]

Published
2022

45. Daxor Corporation to Showcased the Benefits of BVA-100(r) Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 18th Annual Meeting

Subjects
Daxor Corp. -- Conferences, meetings and seminars, Trade and professional associations -- Conferences, meetings and seminars, Medical test kit industry -- Conferences, meetings and seminars, Medical equipment and supplies industry -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Nurses -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, Business, international
Abstract

Oak Ridge, TN,: Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American Association of Heart Failure Nurses (AAHFN) 18th [...]

Published
2022

47. Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences

Subjects
Cardiovascular Systems Inc. -- Conferences, meetings and seminars, Coronary heart disease -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Business, Business, international
Abstract

ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI([R])) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today [...]

Published
2022

49. Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference

Subjects
Cardiovascular Systems Inc. -- Conferences, meetings and seminars, Coronary heart disease -- Conferences, meetings and seminars, Medical test kit industry -- Conferences, meetings and seminars, Medical equipment and supplies industry -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

ST. PAUL, Minn.: Cardiovascular Systems, Inc. has issued the following news release: Cardiovascular Systems, Inc. (CSI(r)) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for [...]

Published
2022

50. At the inaugural Technology and Heart Failure Therapeutics Conference, Ancora Heart announces key activities

Subjects
Conferences and conventions -- Conferences, meetings and seminars, Cardiac patients -- Conferences, meetings and seminars, Heart -- Conferences, meetings and seminars, Heart failure -- Conferences, meetings and seminars, General interest, News, opinion and commentary
Abstract

SANTA CLARA, Calif.: Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure, today announced its activities at the upcoming, first ever Technology and Heart [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results